← Back to Insights
October 29, 2025
Authors
David Burda
Topics
Consumerism Economics Outcomes
Channels
Blogs

A Shock to the System

Some people have called me a hypochondriac. Others have said I display hypochondriac tendencies. I deny both characterizations.

Still, I did immediately stop what I was doing to read a new study on automated external defibrillations (AEDs) in the home. I’m not interested for personal use, mind you. I’m here because I have a professional interest in people becoming their own doctors as increasingly sophisticated diagnostic and treatment technology becomes available for home use and is forever changing the healthcare market.

Seriously. I wrote about that trend in a monthly column last year called “The Doctor Is in the House.”

The question raised by the new study is whether consumers should add home AEDs to their inventory of personal diagnostic and treatment gizmos they keep in their medical closets. The study, which appeared in JAMA Internal Medicine, said it’s not worth it. Here are the details.

No less than 12 health services researchers conducted the study, most of them from Denmark and The Netherlands, which analyzed data from something called the Cardiac Arrest Registry to Enhance Survival (CARES). The Centers for Disease Control and Prevention, when it was a functioning public health agency of the U.S. government, and Emory University School of Medicine’s Department of Emergency Medicine built CARES to track instances of out-of-hospital cardiac arrests (OHCAs). The CARES website says OHCAs happen about 350,000 times a year in the U.S., and about 90% of those people die.

The researchers wanted to know how effective AEDs in the home are in saving people who drop where they live and whether that effectiveness was worth the cost of buying and maintaining a home AED.

The study pool was nearly 600,000 people who suffered cardiac arrest in their homes from January 2017 through December 2024. Of those people, only 777, or 0.1%, received a shock from an AED from a family member or friend before paramedics arrived.

Of the 618 people with non-shockable rhythms, only 29, or 4.7%, survived until hospital discharge. Of the 159 people with shockable rhythms, 45, or 28.3%, survived until hospital discharge. That compares with 4.4% and 21.7%, respectively, for all the people who didn’t get shocked at home from an AED.

Then, using some fancy math, the researchers calculated whether purchasing an AED for home use at $1,620 would be cost effective given the similar mortality outcomes. They said answer is no, it wouldn’t. Extrapolated out, that $1,620 turns into $4.5 million per quality-adjusted life years (QALYs) gained.

“The indiscriminate purchase of AEDs for individual private homes cannot be considered cost-effective at the current pricing of AEDs,” the researchers said, adding that the price of an AED would need to drop to $65 to make the math work and change their minds.

Just for grins, I looked at the demographics of the people in the study who arrested at home: 62% were male, 51% were white and their median age was 65. Hmmmm.

Thanks for reading.

About the Author

David Burda

David Burda began covering healthcare in 1983 and hasn’t stopped since. Dave writes this monthly column “Burda on Healthcare,” contributes weekly blog posts, manages our weekly newsletter 4sight Friday, and hosts our weekly Roundup podcast. Dave believes that healthcare is a business like any other business, and customers — patients — are king. If you do what’s right for patients, good business results will follow.

Dave’s personal experiences with the healthcare system both as a patient and family caregiver have shaped his point of view. It’s also been shaped by covering the industry for 40 years as a reporter and editor. He worked at Modern Healthcare for 25 years, the last 11 as editor.

Prior to Modern Healthcare, he did stints at the American Medical Record Association (now AHIMA) and the American Hospital Association. After Modern Healthcare, he wrote a monthly column for Twin Cities Business explaining healthcare trends to a business audience, and he developed and executed content marketing plans for leading healthcare corporations as the editorial director for healthcare strategies at MSP Communications.

When he’s not reading and writing about healthcare, Dave spends his time riding the trails of DuPage County, IL, on his bike, tending his vegetable garden and daydreaming about being a lobster fisherman in Maine. He lives in Wheaton, IL, with his lovely wife of 40 years and his three children, none of whom want to be journalists or lobster fishermen.

Recent Posts

Outcomes
Where Spending More Means a Lot Less
You probably know by now that I turned 65 in April, and I’m now a Medicare beneficiary. I’m… Read More
By October 22, 2025
Economics
Podcast: Measuring the ROI of Safe and Effective Care 10/16/25
They say good outcomes are good business in healthcare. But can anyone prove it? We talked about that… Read More
By October 16, 2025
Economics
Burda on Healthcare: Fat Shaming Our Way to Lower Health Insurance Premiums
I’m overweight. I have been for most of my life. I’m on five prescription medications. Four keep my… Read More
By October 14, 2025